Myopia is a refractive error (blurred vision at a given distance) that affects about 30% of the world's population. This proportion is increasing so quickly that it ...
Three studies showed that adults aged 20 to 50 years with myopia experienced about –1 D of progression. Most progression occurred between 20 and 30 years of age. Perspective from Alexander ...
If approved, SYD-101 would be the first pharmaceutical treatment to slow the progression of pediatric myopia in the U.S. The FDA accepted a new drug application for SYD-101 to slow the progression ...
Langis Michaud has received research funding from Bausch and Lomb, Neurolens and Fitlens. He has received speaker's fees from Johnson and Johnson and Essilor. Université de Montréal provides ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback